DD143077A5 - Verfahren zur herstellung von 1,3-dibenzoesaeureestern des 17alpha-ethinyl-7alpha-methyl-1,3,5(10)-oestratrien-1,3,17beta-triols - Google Patents

Verfahren zur herstellung von 1,3-dibenzoesaeureestern des 17alpha-ethinyl-7alpha-methyl-1,3,5(10)-oestratrien-1,3,17beta-triols Download PDF

Info

Publication number
DD143077A5
DD143077A5 DD79212298A DD21229879A DD143077A5 DD 143077 A5 DD143077 A5 DD 143077A5 DD 79212298 A DD79212298 A DD 79212298A DD 21229879 A DD21229879 A DD 21229879A DD 143077 A5 DD143077 A5 DD 143077A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
preparation
ethinyl
estratrien
ethynyl
Prior art date
Application number
DD79212298A
Other languages
German (de)
English (en)
Inventor
Klaus Prezewowsky
Hermann Steinbeck
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD143077A5 publication Critical patent/DD143077A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD79212298A 1978-04-21 1979-04-18 Verfahren zur herstellung von 1,3-dibenzoesaeureestern des 17alpha-ethinyl-7alpha-methyl-1,3,5(10)-oestratrien-1,3,17beta-triols DD143077A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782818164 DE2818164A1 (de) 1978-04-21 1978-04-21 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
DD143077A5 true DD143077A5 (de) 1980-07-30

Family

ID=6037985

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79212298A DD143077A5 (de) 1978-04-21 1979-04-18 Verfahren zur herstellung von 1,3-dibenzoesaeureestern des 17alpha-ethinyl-7alpha-methyl-1,3,5(10)-oestratrien-1,3,17beta-triols

Country Status (17)

Country Link
US (1) US4259325A (da)
EP (1) EP0004898B1 (da)
JP (1) JPS54141756A (da)
AT (1) AT366065B (da)
AU (1) AU521011B2 (da)
CA (1) CA1123426A (da)
CS (1) CS203036B2 (da)
DD (1) DD143077A5 (da)
DE (2) DE2818164A1 (da)
DK (1) DK153279A (da)
ES (1) ES479691A1 (da)
GR (1) GR73572B (da)
HU (1) HU179069B (da)
IE (1) IE48133B1 (da)
IL (1) IL57072A (da)
SU (1) SU843757A3 (da)
YU (1) YU78679A (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
US4757062A (en) * 1985-11-01 1988-07-12 E. I. Du Pont De Nemours And Company Substituted benzoate ester prodrugs of estrogens
US5188835A (en) * 1986-06-16 1993-02-23 Kabi Pharmacia Ab Intravaginal devices
ES2218556T3 (es) 1994-11-22 2004-11-16 Balance Pharmaceuticals, Inc. Metodos de contracepcion.
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
JP5357108B2 (ja) * 2010-06-29 2013-12-04 大陽日酸株式会社 バーナの燃焼方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861086A (en) * 1957-12-27 1958-11-18 Searle & Co 17-oxygenated estra-1, 3, 5(10)-triene-1, 3-diols, and the corresponding esters and ethers
US3024256A (en) * 1961-02-20 1962-03-06 Searle & Co 16-substituted 1, 3-diacyloxyestra-1, 3, 5(10)-trien-17-ones
DE1240859B (de) * 1963-11-09 1967-05-24 Schering Ag Verfahren zur Herstellung von Androstan-1alpha, 3alpha, 17beta-triol und seinen Estern
FR1580268A (da) * 1968-06-10 1969-09-05
US3574197A (en) * 1968-07-09 1971-04-06 Schering Ag Process of producing 1-hydroxy-7alpha-methyl-estradiol derivatives
US3951959A (en) * 1973-07-13 1976-04-20 Schering Aktiengesellschaft 1,3-Oxygenated 8α-estratrienes

Also Published As

Publication number Publication date
CS203036B2 (en) 1981-02-27
ATA296079A (de) 1981-07-15
CA1123426A (en) 1982-05-11
DE2962423D1 (en) 1982-05-19
IE48133B1 (en) 1984-10-03
IL57072A (en) 1982-07-30
EP0004898A1 (de) 1979-10-31
IL57072A0 (en) 1979-07-25
DE2818164A1 (de) 1979-10-31
IE790821L (en) 1979-10-21
AU4627679A (en) 1979-10-25
AU521011B2 (en) 1982-03-11
DK153279A (da) 1979-10-22
YU78679A (en) 1983-02-28
AT366065B (de) 1982-03-10
GR73572B (da) 1984-03-19
JPS54141756A (en) 1979-11-05
EP0004898B1 (de) 1982-04-07
ES479691A1 (es) 1979-08-01
HU179069B (en) 1982-08-28
US4259325A (en) 1981-03-31
SU843757A3 (ru) 1981-06-30

Similar Documents

Publication Publication Date Title
US4312864A (en) Branched chain and cycloaliphatic esters of the androstane and destrane series and pharmaceutical compositions containing same
DD143077A5 (de) Verfahren zur herstellung von 1,3-dibenzoesaeureestern des 17alpha-ethinyl-7alpha-methyl-1,3,5(10)-oestratrien-1,3,17beta-triols
JPS624400B2 (da)
EP0318490B1 (de) 14,17-g(b)-ETHANO-14-g(b)-ESTRATRIENE, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE
DE3838779A1 (de) 14(alpha),17(alpha)-ethano-estratriene
DE4326240A1 (de) 15,15-Dialkyl-substituierte Derivate des Estradiols
DE60003074T2 (de) Fusidinsäure-derivate
US3310470A (en) Androstane-1alpha, 3alpha, 17beta-triol and fatty acid esters thereof
EP0034114B1 (de) 3-Desoxy-delta-15-Steroide, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
EP0031591A1 (de) 2,2-Dimethyl-3-oxoandrosta-4,6-dien-17S-spiro-5'-(2'-oxo-3'-methyloxazolidin), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
US3240671A (en) Therapeutic composition containing the 3-cyclopentyl enol ether of 17alpha-acetoxy progesterone and method of using the same
DE60026608T2 (de) 3-methylen steroid derivate zur behandlung von autoimmunerkrankungen
AT270887B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
DE1493165C3 (de) 1 -Hydroxyöstradiol-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel
AT272535B (de) Verfahren zur Herstellung von neuen 6-Fluormethyl-3-oxo-4,6-dien-steroiden der Pregnanreihe
DE1815464C (de) 3 Oxo-gonatnene sowie diese enthalten de pharmazeutische Zusammensetzungen
EP0513947B1 (de) 14Alpha,16alpha-Ethano- und 14alpha,16alpha-Ethenoestratriene
DE2109305B2 (de) 20-Hydroxylierte 17 a - MethyI-19-nor-pregna-4,9diene, Verfahren zu deren Herstellung sowie Zwischenprodukte
DE1468302C3 (de) 6-Chk>r-4,6-pregnadlen-3 beta, 17 alpha-dlol-20-on-diacetat sowie Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitungen
CH616433A5 (en) Process for the preparation of 18,18-difluorosteroids.
DE19548449A1 (de) 17alpha-Cyanomethyl-3-oxyiminoestra-4,9-dien-3-on-17beta-yl-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE1966505A1 (de) Oral wirksames ovulations-verhinderndes mittel
DE1174778B (de) Verfahren zur Herstellung von 3, 4-Dimethyl-?-oestratrien-1, 17ª‰-diol
DE1593509A1 (de) 1-Hydroxy-7alpha-methyl-oestradiol-Derivate
DE1966504A1 (de) Oral wirksames konzeptionsverhinderndes mittel